Loading
PDBj
English日本語简体中文繁體中文한국어
✖
ﾒﾆｭｰPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
Search by PDB author
4G5Z
DownloadVisualize
BU of 4g5z by Molmil
Crystal structure of the therapeutical antibody fragment of canakinumab in its unbound state
分子名称: canakinumab antibody fragment heavy chain, canakinumab antibody fragment light chain
著者Blech, M, Hoerer, S.
登録日2012-07-18
公開日2012-12-19
最終更新日2023-09-13
実験手法X-RAY DIFFRACTION (1.83 Å)
主引用文献One target-two different binding modes: Structural insights into gevokizumab and canakinumab interactions to interleukin-1beta
J.Mol.Biol., 425, 2013
4G6M
DownloadVisualize
BU of 4g6m by Molmil
Crystal structure of human IL-1beta in complex with therapeutic antibody binding fragment of gevokizumab
分子名称: Interleukin-1 beta, heavy chain of gevokizumab antibody binding fragment, light chain of gevokizumab antibody binding fragment
著者Blech, M, Hoerer, S.
登録日2012-07-19
公開日2012-12-19
最終更新日2023-09-13
実験手法X-RAY DIFFRACTION (1.81 Å)
主引用文献Crystal structure of human IL-1beta in complex with therapeutic antibody binding fragment of gevokizumab
J.Mol.Biol., 425, 2013
4EOW
DownloadVisualize
BU of 4eow by Molmil
Crystal structure of a disease-associated anti-human GM-CSF autoantibody MB007
分子名称: MB007 IgG1 Fab fragment light chain, MB007 human IgG1 Fab fragment heavy chain
著者Blech, M.
登録日2012-04-16
公開日2012-08-22
最終更新日2024-03-06
実験手法X-RAY DIFFRACTION (1.97 Å)
主引用文献Molecular structure of human GM-CSF in complex with a disease-associated anti-human GM-CSF autoantibody and its potential biological implications.
Biochem.J., 447, 2012
4G6J
DownloadVisualize
BU of 4g6j by Molmil
Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
分子名称: Interleukin-1 beta, heavy chain of antibody binding fragment of canakinumab, light chain of antibody binding fragment of canakinumab
著者Blech, M, Hoerer, S.
登録日2012-07-19
公開日2012-12-19
最終更新日2023-09-13
実験手法X-RAY DIFFRACTION (2.03 Å)
主引用文献One traget-two different binding modes: Structural insights into gevokizumab and canakinumab interactions to interleukin-1beta
J.Mol.Biol., 425, 2013
4G6K
DownloadVisualize
BU of 4g6k by Molmil
Crystal structure of the therapeutic antibody binding fragment of gevokizumab in its unbound state
分子名称: heavy chain of gevokizumab antibody binding fragment, light chain of gevokizumab antibody binding fragment
著者Blech, M, Hoerer, S.
登録日2012-07-19
公開日2012-12-19
最終更新日2023-09-13
実験手法X-RAY DIFFRACTION (1.9 Å)
主引用文献One target-two different binding modes: Structural insights into gevokizumab and canakinumab interactions to interleukin-1beta
J.Mol.Biol., 425, 2013
6GFE
DownloadVisualize
BU of 6gfe by Molmil
High-resolution Structure of a therapeutic full-length anti-NPRA Antibody with exceptional Conformational Diversity
分子名称: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ACETATE ION, CALCIUM ION, ...
著者Hoerer, S.
登録日2018-04-30
公開日2019-05-15
最終更新日2020-07-29
実験手法X-RAY DIFFRACTION (1.8 Å)
主引用文献Structure of a Therapeutic Full-Length Anti-NPRA IgG4 Antibody: Dissecting Conformational Diversity.
Biophys.J., 116, 2019

222926

件を2024-07-24に公開中

PDB statisticsPDBj update infoContact PDBjnumon